News Announcement

Shasun Pharmaceuticals: Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

S Vimal Kumar & V Leela has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.